Julie R. Palmer

Julie R. Palmer

Auto-generated profile, based on publicly available information

Julie R. Palmer

Slone Epidemiology Center at Boston University, Boston, MA, USA

Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 October 2011 in New England Journal of Medicine
Verified
Journal Article
Open access
PDF file
RHRobert N. Hoover
Robert N. Hoover
MHMarianne Hyer
Marianne Hyer
RPRuth M. Pfeiffer
Ruth M. Pfeiffer
EAErvin Adam
Ervin Adam
BBBrian Bond
Brian Bond
RTRebecca Troisi
Rebecca Troisi
Before 1971, several million women were exposed in utero to diethylstilbestrol (DES) given to their mothers to prevent pregnancy complications. Several adverse outcomes have been linked to such exposure, but their cumulative effects are not well understood. We combined data from three studies initiated in the 1970s with continued long-term follow-up of 4653 women exposed in utero to DES and 1927 unexposed controls. We assessed the risks of 12 adverse outcomes linked to DES exposure, including cumulative risks to 45 years of age for reproductive outcomes and to 55 years of age for other outcomes, and their relationships to the baseline presence or absence of vaginal epithelial changes, which are correlated with a higher dose of, and earlier exposure to, DES in utero. Cumulative risks in women exposed to DES, as compared with those not exposed, were as follows: for infertility, 33.3% vs. 15.5% (hazard ratio, 2.37; 95% confidence interval [CI], 2.05 to 2.75); spontaneous abortion, 50.3% vs. 38.6% (hazard ratio, 1.64; 95% CI, 1.42 to 1.88); preterm delivery, 53.3% vs. 17.8% (hazard ratio, 4.68; 95% CI, 3.74 to 5.86); loss of second-trimester pregnancy, 16.4% vs. 1.7% (hazard ratio, 3.77; 95% CI, 2.56 to 5.54); ectopic pregnancy, 14.6% vs. 2.9% (hazard ratio, 3.72; 95% CI, 2.58 to 5.38); preeclampsia, 26.4% vs. 13.7% (hazard ratio 1.42; 95% CI, 1.07 to 1.89); stillbirth, 8.9% vs. 2.6% (hazard ratio, 2.45; 95% CI, 1.33 to 4.54); early menopause, 5.1% vs. 1.7% (hazard ratio, 2.35; 95% CI, 1.67 to 3.31); grade 2 or higher cervical intraepithelial neoplasia, 6.9% vs. 3.4% (hazard ratio, 2.28; 95% CI, 1.59 to 3.27); and breast cancer at 40 years of age or older, 3.9% vs. 2.2% (hazard ratio, 1.82; 95% CI, 1.04 to 3.18). For most outcomes, the risks among exposed women were higher for those with vaginal epithelial changes than for those without such changes. In utero exposure of women to DES is associated with a high lifetime risk of a broad spectrum of adverse health outcomes. (Funded by the National Cancer Institute.)

9 September 2008 in PLOS Medicine
Verified
Journal Article
Open access
PDF file
MTMichael J Thun
Michael J Thun
LHLindsay M Hannan
Lindsay M Hannan
LALucile L Adams-Campbell
Lucile L Adams-Campbell
PBPaolo Boffetta
Paolo Boffetta
JBJulie E Buring
Julie E Buring
JSJon M Samet
Jon M Samet
Better information on lung cancer occurrence in lifelong nonsmokers is needed to understand gender and racial disparities and to examine how factors other than active smoking influence risk in different time periods and geographic regions. We pooled information on lung cancer incidence and/or death rates among self-reported never-smokers from 13 large cohort studies, representing over 630,000 and 1.8 million persons for incidence and mortality, respectively. We also abstracted population-based data for women from 22 cancer registries and ten countries in time periods and geographic regions where few women smoked. Our main findings were: (1) Men had higher death rates from lung cancer than women in all age and racial groups studied; (2) male and female incidence rates were similar when standardized across all ages 40+ y, albeit with some variation by age; (3) African Americans and Asians living in Korea and Japan (but not in the US) had higher death rates from lung cancer than individuals of European descent; (4) no temporal trends were seen when comparing incidence and death rates among US women age 40–69 y during the 1930s to contemporary populations where few women smoke, or in temporal comparisons of never-smokers in two large American Cancer Society cohorts from 1959 to 2004; and (5) lung cancer incidence rates were higher and more variable among women in East Asia than in other geographic areas with low female smoking. These comprehensive analyses support claims that the death rate from lung cancer among never-smokers is higher in men than in women, and in African Americans and Asians residing in Asia than in individuals of European descent, but contradict assertions that risk is increasing or that women have a higher incidence rate than men. Further research is needed on the high and variable lung cancer rates among women in Pacific Rim countries.

14 February 2012 in Circulation
Verified
Journal Article
Closed access
PDF file
PCPatricia F. Coogan
Patricia F. Coogan
LWLaura F White
Laura F White
MJMichael Jerrett
Michael Jerrett
RBRobert D. Brook
Robert D. Brook
JSJason G. Su
Jason G. Su
LRLynn Rosenberg
Lynn Rosenberg
Background—: Evidence suggests that longer-term exposure to air pollutants over years confers higher risks of cardiovascular morbidity and mortality than shorter-term exposure. One explanation is that the cumulative adverse effects that develop over longer durations lead to the genesis of chronic disease. Preliminary epidemiological and clinical evidence suggests that air pollution may contribute to the development of hypertension and type 2 diabetes mellitus. Methods and Results—: We used Cox proportional hazards models to assess incidence rate ratios (IRRs) and 95% confidence intervals (CIs) for incident hypertension and diabetes mellitus associated with exposure to fine particulate matter (PM 2.5 ) and nitrogen oxides in a cohort of black women living in Los Angeles. Pollutant levels were estimated at participants' residential addresses with land use regression models (nitrogen oxides) and interpolation from monitoring station measurements (PM 2.5 ). Over follow-up from 1995 to 2005, 531 incident cases of hypertension and 183 incident cases of diabetes mellitus occurred. When pollutants were analyzed separately, the IRR for hypertension for a 10-μg/m 3 increase in PM 2.5 was 1.48 (95% CI, 0.95–2.31), and the IRR for the interquartile range (12.4 parts per billion) of nitrogen oxides was 1.14 (95% CI, 1.03–1.25). The corresponding IRRs for diabetes mellitus were 1.63 (95% CI, 0.78–3.44) and 1.25 (95% CI, 1.07–1.46). When both pollutants were included in the same model, the IRRs for PM 2.5 were attenuated and the IRRs for nitrogen oxides were essentially unchanged for both outcomes. Conclusion—: Our results suggest that exposure to air pollutants, especially traffic-related pollutants, may increase the risk of type 2 diabetes mellitus and possibly of hypertension.

1 August 2006 in Cancer Epidemiology, Biomarkers & Prevention
Verified
Journal Article
Closed access
JPJulie R. Palmer
Julie R. Palmer
Lauren WiseLauren Wise
Lauren Wise
EHElizabeth E. Hatch
Elizabeth E. Hatch
RTRebecca Troisi
Rebecca Troisi
LTLinda Titus-Ernstoff
Linda Titus-Ernstoff
RHRobert N. Hoover
Robert N. Hoover
It has been hypothesized that breast cancer risk is influenced by prenatal hormone levels. Diethylstilbestrol (DES), a synthetic estrogen, was widely used by pregnant women in the 1950s and 1960s. Women who took the drug have an increased risk of breast cancer, but whether risk is also increased in the daughters who were exposed in utero is less clear. We assessed the relation of prenatal DES exposure to risk of breast cancer in a cohort of DES-exposed and unexposed women followed since the 1970s by mailed questionnaires. Eighty percent of both exposed and unexposed women completed the most recent questionnaire. Self-reports of breast cancer were confirmed by pathology reports. Cox proportional hazards regression was used to compute incidence rate ratios (IRR) for prenatal DES exposure relative to no exposure. During follow-up, 102 incident cases of invasive breast cancer occurred, with 76 among DES-exposed women (98,591 person-years) and 26 among unexposed women (35,046 person-years). The overall age-adjusted IRR was 1.40 [95% confidence interval (95% CI), 0.89-2.22]. For breast cancer occurring at ages ≥40 years, the IRR was 1.91 (95% CI, 1.09-3.33) and for cancers occurring at ages ≥50 years, it was 3.00 (95% CI, 1.01-8.98). Control for calendar year, parity, age at first birth, and other factors did not alter the results. These results, from the first prospective study on the subject, suggest that women with prenatal exposure to DES have an increased risk of breast cancer after age 40 years. The findings support the hypothesis that prenatal hormone levels influence breast cancer risk. (Cancer Epidemiol Biomarkers Prev 2006;15(8):1509–14)

28 July 2008 in Archives of internal medicine (1960)
Verified
Journal Article
Open access
PDF file
JPJulie R. Palmer
Julie R. Palmer
DBDeborah A. Boggs
Deborah A. Boggs
SKSupriya Krishnan
Supriya Krishnan
FHFrank B. Hu
Frank B. Hu
MSMartha Singer
Martha Singer
LRLynn Rosenberg
Lynn Rosenberg
Type 2 diabetes mellitus, a leading cause of morbidity and mortality in the United States, has increased in incidence in recent years, and the mean age at diagnosis has dropped.1Type 2 diabetes is a particular problem among African American women, among whom the incidence rate is twice that of US white women.2 Obesity is the strongest modifiable risk factor for type 2 diabetes,2,3 and much of the excess incidence in African American women is due to their high levels of overweight and obesity.4 It is important to identify modifiable factors that will lead to weight loss or that will reduce risk of type 2 diabetes regardless of whether weight loss occurs.

25 January 1990 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
LRLynn Rosenberg
Lynn Rosenberg
JPJulie R. Palmer
Julie R. Palmer
SSSamuel Shapiro
Samuel Shapiro
To assess the relation of smoking cessation to the risk of a first myocardial infarction in women, we compared the smoking habits of 910 patients who had had their first myocardial infarction with those of 2375 controls in a hospital-based case–control study of women from 25 to 64 years of age.